Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 423 entries
Sorted by: Best Match Show Resources per page
Identification and evaluation of risk of generalizability biases in pilot versus efficacy/effectiveness trials: a systematic review and meta-analysis

Science interventions

Beets MW, Geraci M, Ioannidis J, Weaver RG.
GSID: aDi3MwmGJnAJ
MW Beets, RG Weaver, J Ioannidis, M Geraci… - International Journal of …, 2020 - Springer

Preliminary evaluations of behavioral interventions, referred to as pilot studies, predate the conduct of many large-scale efficacy/effectiveness trial. The ability of a pilot study to inform …

BUSCO: assessing genome assembly and annotation completeness with single-copy orthologs

pipeline programs

Ioannidis P, Simão FA, Waterhouse RM.
GSID: 9H4JGTgg6nkJ
FA Simão, RM Waterhouse, P Ioannidis… - …, 2015 - academic.oup.com

Motivation: Genomics has revolutionized biological research, but quality assessment of the resulting assembled sequences is complicated and remains mostly limited to technical …

Detecting the Hidden Properties of Immunological Data and Predicting the Mortality Risks of Infectious Syndromes.

Frontiers in immunology

Chatzipanagiotou S, Ioannidis A, Trikka-Graphakos E, Charalampaki N, Sereti C, Piccinini R, Higgins AM, Buranda T, Durvasula R, Hoogesteijn AL, Tegos GP, Rivas AL.
PMID: 27375617
Front Immunol. 2016 Jun 10;7:217. doi: 10.3389/fimmu.2016.00217. eCollection 2016.

BACKGROUND: To extract more information, the properties of infectious disease data, including hidden relationships, could be considered. Here, blood leukocyte data were explored to elucidate whether hidden information, if uncovered, could forecast mortality.METHODS: Three sets of individuals (n =...

Effects of Ionic Strength on the Colloidal Stability and Interfacial Assembly of Hydrophobic Ethyl Cellulose Nanoparticles.

Langmuir : the ACS journal of surfaces and colloids

Bizmark N, Ioannidis MA.
PMID: 26241005
Langmuir. 2015 Sep 01;31(34):9282-9. doi: 10.1021/acs.langmuir.5b01857. Epub 2015 Aug 20.

Nanoparticle attachment at a fluid interface is a process that often takes place concurrently with nanoparticle aggregation in the bulk of the suspension. Here we investigate systematically the coupling of these processes with reference to the adsorption of aqueous...

Spotlight on vismodegib in the treatment of basal cell carcinoma: an evidence-based review of its place in therapy.

Clinical, cosmetic and investigational dermatology

Apalla Z, Papageorgiou C, Lallas A, Sotiriou E, Lazaridou E, Vakirlis E, Kyrgidis A, Ioannides D.
PMID: 28546761
Clin Cosmet Investig Dermatol. 2017 May 10;10:171-177. doi: 10.2147/CCID.S101330. eCollection 2017.

Vismodegib is approved for the treatment of adult patients with metastatic (mBCC) or locally advanced basal cell carcinoma (laBCC) that have recurred following surgery or for those who are not good candidates for surgery (risk/benefit ratio is against patient's...

A multidisciplinary approach to unplanned conversion from off-pump to on-pump beating heart coronary artery revascularization in patients with compromised left ventricular function.

Critical care research and practice

Tsaousi G, Pitsis AA, Ioannidis GD, Vasilakos DG.
PMID: 25478216
Crit Care Res Pract. 2014;2014:348021. doi: 10.1155/2014/348021. Epub 2014 Nov 12.

Aim. To comparably assess the perioperative risk factors that differentiate off-pump coronary artery bypass (OPCAB) grafting cases from those sustaining unplanned conversion to on-pump beating heart (ONCAB/BH) approach, in patients with left ventricular ejection fraction (LVEF) < 40%. Methods....

Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis.

PLoS medicine

Rhee SY, Blanco JL, Jordan MR, Taylor J, Lemey P, Varghese V, Hamers RL, Bertagnolio S, de Wit TF, Aghokeng AF, Albert J, Avi R, Avila-Rios S, Bessong PO, Brooks JI, Boucher CA, Brumme ZL, Busch MP, Bussmann H, Chaix ML, Chin BS, D'Aquin TT, De Gascun CF, Derache A, Descamps D, Deshpande AK, Djoko CF, Eshleman SH, Fleury H, Frange P, Fujisaki S, Harrigan PR, Hattori J, Holguin A, Hunt GM, Ichimura H, Kaleebu P, Katzenstein D, Kiertiburanakul S, Kim JH, Kim SS, Li Y, Lutsar I, Morris L, Ndembi N, Kee PN, Paranjape RS, Peeters M, Poljak M, Price MA, Ragonnet-Cronin ML, Reyes-Terán G, Rolland M, Sirivichayakul S, Smith DM, Soares MA, Soriano VV, Ssemwanga D, Stanojevic M, Stefani MA, Sugiura W, Sungkanuparph S, Tanuri A, Tee KK, Truong HM, van de Vijver DA, Vidal N, Yang C, Yang R, Yebra G, Ioannidis JP, Vandamme AM, Shafer RW.
PMID: 26030872
PLoS Med. 2015 Jun 01;12(6):e1001845. doi: 10.1371/journal.pmed.1001845. eCollection 2015 Jun.

No abstract available.

Correction: Multiple Citation Indicators and Their Composite across Scientific Disciplines.

PLoS biology

Ioannidis JP, Klavans R, Boyack KW.
PMID: 27548059
PLoS Biol. 2016 Aug 22;14(8):e1002548. doi: 10.1371/journal.pbio.1002548. eCollection 2016 Aug.

[This corrects the article DOI: 10.1371/journal.pbio.1002501.].

Anticipating consequences of sharing raw data and code and of awarding badges for sharing.

Journal of clinical epidemiology

Ioannidis JP.
PMID: 26163123
J Clin Epidemiol. 2016 Feb;70:258-60. doi: 10.1016/j.jclinepi.2015.04.015. Epub 2015 Jul 08.

No abstract available.

Corrigendum: Simple, standardized incorporation of genetic risk into non-genetic risk prediction tools for complex traits: coronary heart disease as an example.

Frontiers in genetics

Goldstein BA, Knowles JW, Salfati E, Ioannidis JP, Assimes TL.
PMID: 26217377
Front Genet. 2015 Jul 07;6:231. doi: 10.3389/fgene.2015.00231. eCollection 2015.

[This corrects the article on p. 254 in vol. 5, PMID: 25136350.].

Renal replacement therapy in Europe: a summary of the 2011 ERA-EDTA Registry Annual Report.

Clinical kidney journal

Noordzij M, Kramer A, Abad Diez JM, Alonso de la Torre R, Arcos Fuster E, Bikbov BT, Bonthuis M, Bouzas Caamaño E, Čala S, Caskey FJ, Castro de la Nuez P, Cernevskis H, Collart F, Díaz Tejeiro R, Djukanovic L, Ferrer-Alamar M, Finne P, García Bazaga Mde L, Garneata L, Golan E, Gonzalez Fernández R, Heaf JG, Hoitsma A, Ioannidis GA, Kolesnyk M, Kramar R, Lasalle M, Leivestad T, Lopot F, van de Luijtgaarden MW, Macário F, Magaz Á, Martín Escobar E, de Meester J, Metcalfe W, Ots-Rosenberg M, Palsson R, Piñera C, Pippias M, Prütz KG, Ratkovic M, Resić H, Rodríguez Hernández A, Rutkowski B, Spustová V, Stel VS, Stojceva-Taneva O, Süleymanlar G, Wanner C, Jager KJ.
PMID: 25852881
Clin Kidney J. 2014 Apr;7(2):227-38. doi: 10.1093/ckj/sfu007. Epub 2014 Mar 02.

BACKGROUND: This article provides a summary of the 2011 ERA-EDTA Registry Annual Report (available at www.era-edta-reg.org).METHODS: Data on renal replacement therapy (RRT) for end-stage renal disease (ESRD) from national and regional renal registries in 30 countries in Europe and...

Current use of routinely collected health data to complement randomized controlled trials: a meta-epidemiological survey.

CMAJ open

Hemkens LG, Contopoulos-Ioannidis DG, Ioannidis JP.
PMID: 27398355
CMAJ Open. 2016 Apr 06;4(2):E132-40. doi: 10.9778/cmajo.20150036. eCollection 2016.

BACKGROUND: Studies that use routinely collected health data (RCD studies) are advocated to complement evidence from randomized controlled trials (RCTs) for comparative effectiveness research and to inform health care decisions when RCTs would be unfeasible. We aimed to evaluate...

Showing 1 to 12 of 423 entries